GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » Shares Outstanding (EOP)

Suzhou Basecare Medical (HKSE:02170) Shares Outstanding (EOP) : 273.5 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Suzhou Basecare Medical's shares outstanding for the quarter that ended in Dec. 2023 was 273.5 Mil.

Suzhou Basecare Medical's quarterly shares outstanding stayed the same from Jun. 2023 (273.5 Mil) to Dec. 2023 (273.5 Mil).

Suzhou Basecare Medical's annual shares outstanding stayed the same from Dec. 2022 (273.5 Mil) to Dec. 2023 (273.5 Mil).


Suzhou Basecare Medical Shares Outstanding (EOP) Historical Data

The historical data trend for Suzhou Basecare Medical's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical Shares Outstanding (EOP) Chart

Suzhou Basecare Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial 266.67 266.67 273.53 273.53 273.53

Suzhou Basecare Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only 273.53 273.53 273.53 273.53 273.53

Competitive Comparison of Suzhou Basecare Medical's Shares Outstanding (EOP)

For the Medical Devices subindustry, Suzhou Basecare Medical's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Basecare Medical's Shares Outstanding (EOP) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's Shares Outstanding (EOP) falls into.



Suzhou Basecare Medical Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Suzhou Basecare Medical  (HKSE:02170) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Suzhou Basecare Medical Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Basecare Medical (HKSE:02170) Business Description

Traded in Other Exchanges
N/A
Address
BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.
Executives
Orbimed Capital Llc 2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited 2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited 2101 Beneficial owner
Dawn Capital Fund 2101 Beneficial owner
Dawn Capital Limited 2102 Investment manager
Hh Spr-xiv Cy Holdings Limited 2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited 2101 Beneficial owner
Hh Spr-xiv Holdings L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd. 2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines